Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Share-based Compensation: 2018-2024

Historic Share-based Compensation for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $19.9 million.

  • Therapeutics' Share-based Compensation rose 3.61% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.9 million, marking a year-over-year increase of 16.64%. This contributed to the annual value of $19.9 million for FY2024, which is 16.64% up from last year.
  • As of FY2024, Therapeutics' Share-based Compensation stood at $19.9 million, which was up 16.64% from $17.1 million recorded in FY2023.
  • Therapeutics' 5-year Share-based Compensation high stood at $19.9 million for FY2024, and its period low was $8.7 million during FY2020.
  • For the 3-year period, Therapeutics' Share-based Compensation averaged around $16.1 million, with its median value being $17.1 million (2023).
  • Data for Therapeutics' Share-based Compensation shows a peak YoY skyrocketed of 323.50% (in 2020) over the last 5 years.
  • Over the past 5 years, Therapeutics' Share-based Compensation (Yearly) stood at $8.7 million in 2020, then climbed by 14.58% to $10.0 million in 2021, then climbed by 13.18% to $11.3 million in 2022, then soared by 51.73% to $17.1 million in 2023, then grew by 16.64% to $19.9 million in 2024.